Rescue of chemorefractory classical Hodgkin lymphoma with nivolumab and autologous stem-cell transplantation: Real-life experience

Buccheri Valeria; Fatobene Giancarlo; Santos Fernanda M.; Velasques Rodrigo D.; Bellesso Marcelo; Atanazio Marcelo J.; Rocha Vanderson

首页> 外文期刊>Hematological oncology >Rescue of chemorefractory classical Hodgkin lymphoma with nivolumab and autologous stem-cell transplantation: Real-life experience

【24h】

Rescue of chemorefractory classical Hodgkin lymphoma with nivolumab and autologous stem-cell transplantation: Real-life experience

机译：用Nivolumab和自体干细胞移植拯救化学惯性古典霍奇金淋巴瘤：现实生活经验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hematological oncology》 |2021年第1期|共3页
作者
Buccheri Valeria; Fatobene Giancarlo; Santos Fernanda M.; Velasques Rodrigo D.; Bellesso Marcelo; Atanazio Marcelo J.; Rocha Vanderson;
展开▼
作者单位

Univ Sao Paulo Fac Med Hosp Clin Div Hematol Sao Paulo Brazil;

Univ Sao Paulo Fac Med Hosp Clin Div Hematol Sao Paulo Brazil;

Inst Canc Estado Sao Paulo Hematol Div Sao Paulo Brazil;

Inst Canc Estado Sao Paulo Hematol Div Sao Paulo Brazil;

Inst Canc Estado Sao Paulo Hematol Div Sao Paulo Brazil;

Univ Sao Paulo Fac Med Hosp Clin Div Hematol Sao Paulo Brazil;

Univ Sao Paulo Fac Med Hosp Clin Div Hematol Sao Paulo Brazil;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. A NOVEL PREPARATORY REGIMEN INCLUDING BUSULFAN, ETOPOSIDE AND CYCLOPHOSPHAMIDE FOR AUTOLOGOUS TRANSPLANTATION IN HODGKIN AND NON-HODGKIN LYMPHOMA AND MULTIPLE MYELOMA [J] . EACopelan, BBolwell, JLKlien, 中华医学杂志：英文版 . 1994,第010期
2. Prognostic value of pre-and post-transplantation 18F-fluorodeoxyglucose positron emission tomography results in non-Hodgkin lymphoma patients receiving autologous stem cell transplantation [J] . Zhitao Ying, Meifeng Tu, Yan Xie, 中国癌症研究（英文版） . 2017,第006期
3. HIGH DOSE CHEMORADIOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE TREATMENT OF ADVANCED HODGKIN'S LYMPHOMA: A REPORT OF 11 CASES [J] . 周生余, 石远凯, 何小慧, 中国癌症研究（英文版） . 2002,第004期
4. Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial [J] . Younes Anas, Santoro Armando, Shipp Margaret, The lancet oncology . 2016,第9期

机译：自体干细胞移植和brentuximab vedotin均失败后使用Nivolumab治疗经典霍奇金淋巴瘤：一项多中心，多队列，单组2期试验
5. Nivolumab for Heavily Pretreated Relapsed/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain (Spanish Group of Lymphoma and Bone Marrow Transplantation, GELTAMO) [J] . Martinez Carmen, Carpio Cecilia, Heras Inmaculada, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：Nivolumab用于严重预处理/难治性霍奇金淋巴瘤：西班牙的现实生活经验（西班牙淋巴瘤和骨髓移植，Gellamo）
6. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working [J] . Majolino I, Pearce R, Taghipour G, Journal of Clinical Oncology . 1997,第2期

机译：霍奇金淋巴瘤和非霍奇金淋巴瘤的外周血干细胞移植与自体骨髓移植：欧洲血液和骨髓移植登记数据组的新配对对分析。淋巴瘤工作
7. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
8. Correlates of fatigue in lymphoma patients undergoing autologous peripheral blood stem cell transplantation. [D] . El-Banna, Majeda Mohammed. 2004

机译：与进行自体外周血干细胞移植的淋巴瘤患者疲劳相关。
9. Nivolumab for classical Hodgkin lymphoma after autologous stem-cell transplantation and brentuximab vedotin failure: a prospective phase 2 multi-cohort study [O] . Anas Younes, Armando Santoro, Margaret Shipp, -1

机译：自体干细胞移植和brentuximab vedotin衰竭后Nivolumab治疗经典霍奇金淋巴瘤：前瞻性2期多队列研究
10. NIVOLUMAB FOR RELAPSED OR REFRACTORY (R/R) CLASSICAL HODGKIN LYMPHOMA (CHL) AFTER AUTOLOGOUS TRANSPLANTATION: 5‐YEAR OVERALL SURVIVAL FROM THE PHASE 2 CHECKMATE 205 STUDY [O] . S. M. Ansell, P. J. Bröckelmann, G. Keudell, 2021

机译：生物移植后的复发或难治性（R / R）古典霍奇金淋巴瘤（CHL）中的Nivolumab：5年的阶段2阶段的总生存率205研究
11. Autologous Peripheral Stem-Cell Transplantation. Health Technology AssessmentNumber 5 [R] . Handelsman, H. 1995

机译：自体外周干细胞移植。卫生技术评估编号5

Rescue of chemorefractory classical Hodgkin lymphoma with nivolumab and autologous stem-cell transplantation: Real-life experience

著录项

相似文献

相关主题

期刊订阅